Doctor profile · Federal record
Dr. BALESH SHARMA, MD
Medical Oncology Physician (CMS: MEDICAL ONCOLOGY) · Hematology & Oncology Physician · BROWNSVILLE, TX
- NPI 1578505483
- Accepts Medicare
- MIPS 86.7 / 100 · 2023
- 36 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2150 N EXPRESSWAY
BROWNSVILLE, TX 785211561
(956) 548-0810
fax (956) 548-2198 - Mailing address
-
PO BOX 911230
DALLAS, TX 753911230
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- February 2, 2023
- Year of graduation
- 1990 — 36 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Texas #J9338
- Medicaid (4)
- TX #116608404 · TX #116608405 · TX #116608403 · TX #116608406
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1578505483. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
18,765
Distinct HCPCS
10
Medicare allowed
$301,988
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1756 |
Injection, iron sucrose, 1 mg | 7,200 | 14 | $0 | |
Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 2,950 | 30 | $8 | |
Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,926 | 18 | $0 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 1,068 | 358 | $8 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 940 | 341 | $122 | |
80053 |
Blood test, comprehensive group of blood chemicals | 861 | 345 | $10 | |
36415 |
Insertion of needle into vein for collection of blood sample | 785 | 307 | $8 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 354 | 14 | $0 | |
83540 |
Iron level | 309 | 140 | $6 | |
83550 |
Iron binding capacity | 309 | 140 | $9 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 536. This provider delivers 35× the peer median.Open Payments
Industry payments received
All-time total
$1,552
Transactions
47
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $157.35 | |
| Janssen Biotech, Inc. | 6 | $137.54 | |
| Merck Sharp & Dohme LLC | 3 | $136.84 | |
| Tempus AI, Inc | 3 | $126.93 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $115.69 | |
| Daiichi Sankyo Inc. | 5 | $104.75 | |
| Eisai Inc. | 5 | $89.65 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $81.19 | |
| PFIZER INC. | 4 | $69.69 | |
| Genentech USA, Inc. | 3 | $66.84 | |
| GENZYME CORPORATION | 2 | $63.23 | |
| BeiGene USA, Inc. | 3 | $52.49 | |
| Regeneron Healthcare Solutions, Inc. | 2 | $36.22 | |
| Novartis Pharmaceuticals Corporation | 2 | $35.71 | |
| SOBI, INC | 1 | $29.74 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,142
Patients
291
Total drug cost
$678,311
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 224 | 66 | $5,698 |
| Hydroxyurea | Generic | 131 | 31 | $9,173 |
| Letrozole | Generic | 125 | 21 | $2,809 |
| Levothyroxine Sodium | Generic | 103 | 31 | $1,547 |
| Exemestane | Generic | 83 | 19 | $12,832 |
| Acyclovir | Generic | 56 | 11 | $629 |
| Dexamethasone | Generic | 56 | 25 | $481 |
| Hydromorphone Hcl | Generic | 55 | 13 | $1,716 |
| Prednisone | Generic | 54 | 16 | $501 |
| Morphine Sulfate Er (Morphine Sulfate) | Brand | 53 | 16 | $2,505 |